Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 350
Single User License Price INR 24941
Corporate User License Price USD 1050
Corporate User License Price INR 74823
Site License Price USD 700
Site License Price INR 49882
Request a Quote

Report Title

Biotechnology in Germany

Quote Request for License Type
License Type Price  
Single User License USD 350
Site License USD 700
Enterprise Wide License USD 1050
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Biotechnology in Germany


Quote Request for License Type
License Type Price  
Single User License USD 350
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Biotechnology in Germany

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Biotechnology in Germany



Executive Summary

Biotechnology in Germany

Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The German biotechnology industry had total revenues of USD 9.5bn in 2017, representing a compound annual growth rate (CAGR) of 6.8% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 4.7bn, equivalent to 49.7% of the industry's overall value.

- Germany's biotechnology industry is driven by its aging population, which is raising demand for medical drugs.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Germany biotechnology market by value in 2017?

- What will be the size of the Germany biotechnology market in 2022?

- What factors are affecting the strength of competition in the Germany biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Germany's biotechnology market?

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Boehringer Ingelheim GmbH 20

Merck & Co., Inc. 23

MorphoSys AG 26

Macroeconomic Indicators 29

Country data 29

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Figure 1: Germany biotechnology industry value: USD billion, 2013-17

Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Germany biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Germany, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2017

Figure 11: Boehringer Ingelheim GmbH: revenues & profitability

Figure 12: Boehringer Ingelheim GmbH: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: MorphoSys AG: revenues & profitability

Figure 16: MorphoSys AG: assets & liabilities

List of Tables

Table 1: Germany biotechnology industry value: USD billion, 2013-17

Table 2: Germany biotechnology industry category segmentation: USD billion, 2017

Table 3: Germany biotechnology industry geography segmentation: USD billion, 2017

Table 4: Germany biotechnology industry value forecast: USD billion, 2017-22

Table 5: Boehringer Ingelheim GmbH: key facts

Table 6: Boehringer Ingelheim GmbH: key financials (USD )

Table 7: Boehringer Ingelheim GmbH: key financials (EUR)

Table 8: Boehringer Ingelheim GmbH: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials (USD )

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: MorphoSys AG: key facts

Table 13: MorphoSys AG: key financials (USD )

Table 14: MorphoSys AG: key financials (EUR)

Table 15: MorphoSys AG: key financial ratios

Table 16: Germany size of population (million), 2013-17

Table 17: Germany gdp (constant 2005 prices, USD billion), 2013-17

Table 18: Germany gdp (current prices, USD billion), 2013-17

Table 19: Germany inflation, 2013-17

Table 20: Germany consumer price index (absolute), 2013-17

Table 21: Germany exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person